Deutsche Bank Ag\ Arrowhead Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

A detailed history of Deutsche Bank Ag\ transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 232,451 shares of ARWR stock, worth $5.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

232,451

Previous 242,181 4.02%

Holding current value

$5.83 Million

Previous $7.41 Million 10.28%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.21 - $39.48 $264,753 - $384,140	-9,730 Reduced 4.02%	232,451 $6.65 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $408,990 - $598,630	19,292 Added 8.66%	242,181 $7.41 Million
Q3 2023 Nov 09, 2023	BUY	$26.2 - $36.08 $142,685 - $196,491	5,446 Added 2.5%	222,889 $5.99 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $679,269 - $1.12 Million	-26,998 Reduced 11.04%	217,443 $7.75 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $420,343 - $683,591	17,751 Added 7.83%	244,441 $6.21 Million

Q4 2022 Feb 13, 2023	BUY	$28.0 - $40.56 $144,760 - $209,695	5,170 Added 2.33%	226,690 $9.19 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $3.35 Million - $5.45 Million	-112,902 Reduced 33.76%	221,520 $7.32 Million
Q2 2022 Aug 11, 2022	SELL	$27.79 - $50.61 $204,784 - $372,945	-7,369 Reduced 2.16%	334,422 $11.8 Million
Q1 2022 May 13, 2022	BUY	$39.62 - $69.97 $3.89 Million - $6.87 Million	98,142 Added 40.28%	341,791 $15.7 Million
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $73,483 - $104,375	-1,265 Reduced 0.52%	243,649 $16.2 Million
Q3 2021 Nov 04, 2021	SELL	$58.38 - $84.96 $1.25 Million - $1.82 Million	-21,465 Reduced 8.06%	244,914 $15.3 Million
Q2 2021 Aug 11, 2021	SELL	$62.15 - $90.32 $10.1 Million - $14.7 Million	-163,254 Reduced 38.0%	266,379 $22.1 Million
Q1 2021 May 13, 2021	BUY	$61.35 - $90.47 $7.46 Million - $11 Million	121,527 Added 39.44%	429,633 $28.5 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $5.84 Million - $11.4 Million	133,332 Added 76.29%	308,106 $23.6 Million
Q3 2020 Nov 12, 2020	SELL	$33.21 - $51.27 $710,561 - $1.1 Million	-21,396 Reduced 10.91%	174,774 $7.53 Million
Q2 2020 Aug 13, 2020	BUY	$26.12 - $43.27 $3.19 Million - $5.28 Million	121,998 Added 164.48%	196,170 $8.47 Million
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $6.54 Million - $20.1 Million	-318,002 Reduced 81.09%	74,172 $2.13 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $412,898 - $1.07 Million	14,673 Added 3.89%	392,174 $24.9 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $6.33 Million - $8.4 Million	-240,920 Reduced 38.96%	377,501 $10.6 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $7.01 Million - $11.6 Million	401,953 Added 185.69%	618,421 $16.4 Million
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $2.13 Million - $3.56 Million	176,643 Added 443.55%	216,468 $3.97 Million
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $3.98 Million - $7.3 Million	-370,774 Reduced 90.3%	39,825 $494,000
Q3 2018 Dec 21, 2021	BUY	$14.0 - $20.3 $3.17 Million - $4.6 Million	226,522 Added 123.06%	410,599 $7.87 Million
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $603,274 - $874,747	-43,091 Reduced 18.97%	184,077 $3.53 Million
Q2 2018 Apr 21, 2020	BUY	$6.37 - $14.02 $273,738 - $602,481	42,973 Added 23.33%	227,168 $3.09 Million
Q2 2018 Aug 14, 2018	SELL	$6.37 - $14.02 $335,380 - $738,153	-52,650 Reduced 22.23%	184,195 $2.5 Million
Q1 2018 Oct 18, 2019	BUY	$3.72 - $7.64 $514,457 - $1.06 Million	138,295 Added 140.33%	236,845 $1.71 Million
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $241,632 - $496,256	64,955 Added 193.35%	98,550 $710,000
Q4 2017 Feb 14, 2018	SELL	$3.14 - $4.5 $5,984 - $8,577	-1,906 Reduced 5.37%	33,595 $122,000
Q3 2017 Nov 14, 2017	BUY	$1.69 - $4.33 $59,996 - $153,719	35,501	35,501 $152,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account